Expert Subcommittee Agrees to 2-Year Continuation of Trial of Premium for New Drug Development

The Central Social Insurance Medical Council’s (CSIMC; Chuikyo ) Expert Subcommittee on NHI Drug Pricing Affairs approved on December 16 a proposal by the Ministry of Health, Labor and Welfare (MHLW; Korosho ) to continue the trial of the premium...read more